| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 90 |
| 1 | METHOTREXATE | 88 |
| 2 | CYCLOPHOSPHAMIDE | 58 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 58 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 58 |
| 5 | PREDNISOLONE | 55 |
| 6 | PREDNISOLONE ORAL | 55 |
| 7 | PREDNISOLONE ORAL SOLUTION | 55 |
| 8 | PREDNISONE | 50 |
| 9 | FUROSEMIDE | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELFINAVIR MESYLATE | 9 | 0.0043 |
| 1 | NIZATIDINE | 5 | 0.0033 |
| 2 | AMIKACIN SULFATE | 5 | 0.0029 |
| 3 | VINBLASTINE SULFATE | 5 | 0.0025 |
| 4 | TOPOTECAN HYDROCHLORIDE | 6 | 0.0025 |
| 5 | EPOETIN ALFA | 27 | 0.0023 |
| 6 | TOPOTECAN | 11 | 0.0018 |
| 7 | CLOFARABINE | 4 | 0.0017 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 12 | 0.0016 |
| 9 | IRINOTECAN HYDROCHLORIDE | 18 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 162 |
| 1 | Alkylating Drug [EPC] | 100 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 90 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 84 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 76 |
| 5 | Platinum-based Drug [EPC] | 66 |
| 6 | Loop Diuretic [EPC] | 51 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 42 |
| 8 | Proton Pump Inhibitor [EPC] | 42 |
| 9 | Sulfonamide Antimicrobial [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 1 | Actinomycin [EPC] | 2 | 0.0009 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 14 | 0.0007 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 38 | 0.0007 |
| 4 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 5 | Topoisomerase Inhibitor [EPC] | 41 | 0.0005 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 5 | 0.0005 |
| 7 | Oxazolidinone Antibacterial [EPC] | 14 | 0.0005 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 42 | 0.0004 |
| 9 | Alkylating Drug [EPC] | 100 | 0.0004 |